Biotechnology LAWSUITS FILED AGAINST IRNT, OSCR and AXSM – Jakubowitz Law Pursues Shareholders Claims June 6, 2022
Biotechnology The GBT Foundation Opens 2022 ACCEL Grant Program to Provide Up to $500,000 in Support to Sickle Cell Disease Nonprofit Healthcare Organizations and Institutions June 6, 2022
Biotechnology INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Axsome Therapeutics, Inc. with Losses of $500,000 to Contact the Firm June 6, 2022
Biotechnology ChemoCentryx Reports Safety Results Available from Ongoing Phase I Trial of Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting June 6, 2022
Search
Biotechnology
